Lion’s Mane Deserves a Closer Look
A founder’s perspective, by Shane, Valley Botanicals.
There’s something worth pausing over when a mushroom moves from wellness conversations into a government-funded brain research project.
Researchers at the University of Queensland have been awarded $782,500 through the Medical Research Future Fund to investigate compounds derived from Lion’s Mane.
Not to study the popularity of mushrooms. Not to investigate a passing wellness trend. To explore whether particular molecules could help address cognitive decline.
For me, that raises an interesting question. In a conversation where we rightly need to be careful about claims, are we giving enough attention to the reasons scientists keep looking?
My view is this: funding doesn’t prove every claim about Lion’s Mane, but it does show that its compounds warrant serious scientific investigation.
What the Queensland researchers are investigating
The project brings together Dr Sevannah Steeves from UQ’s Queensland Brain Institute and Dr Kylie Agnew-Francis from its School of Chemistry and Molecular Bioscience.
Their work focuses on naturally occurring molecules derived from Lion’s Mane, known scientifically as Hericium erinaceus.
Of particular interest is how these compounds interact with neurotrophins, molecules that help nerve cells survive, grow and adapt.
In UQ’s announcement, published on 1 July 2026, Dr Steeves explains that neurotrophins are difficult to use as drugs because they cannot easily cross the blood-brain barrier. The researchers are investigating mushroom-derived molecules that can enter the brain and stimulate its own production of these important signalling molecules.
That is a much more specific and interesting story than simply calling Lion’s Mane a “brain mushroom”. It is a question about identifiable compounds, biological pathways and what happens when researchers examine them closely.
This research isn’t starting from nothing
According to UQ, the project builds on earlier preclinical work from its Meunier laboratory, which found that Lion’s Mane compounds enhanced brain-cell growth and improved memory in experimental research.
The new project will investigate whether these compounds can slow or prevent cognitive decline in models of ageing and Alzheimer’s disease. It will also examine the molecular pathways behind their effects.
The Australian Government’s grant record identifies hericene A, a compound derived from Lion’s Mane, as a focus of the work.
Those details matter. This isn’t simply an invitation to see whether a popular mushroom lives up to its reputation. It is a further investigation of biological activity researchers have already observed.
There is a scientific thread here, and the team is following it.
What that funding means to me
As the founder of Valley Botanicals, I pay attention to developments like this because they take the conversation beyond enthusiasm alone.
It is easy for discussions about functional mushrooms to settle into two opposing positions: either every exciting finding becomes a sweeping promise, or anything short of a finished clinical answer is treated as barely worth discussing.
I don’t think either position gives the subject the attention it deserves.
A substantial research grant does not guarantee a successful treatment. Research is funded because important questions remain unanswered. But in this case, the funding is supporting a defined investigation into mushroom-derived compounds, building on earlier laboratory findings.
That gives us a concrete reason to take the research seriously, beyond testimonials, trends or marketing language.
The interesting question isn’t, “Does this grant prove everything people say about Lion’s Mane?” It is, “What have researchers seen that makes this worth pursuing?”
When the answer involves nerve-cell growth, neurotrophin signalling and experimental findings concerning memory, I think that is a story worth telling.
Careful language shouldn’t mean an incurious conversation
There is a difference between making a promise and taking an interest in emerging science.
I want to be able to talk about this work with genuine interest, without turning a research finding into a product promise. Those are not competing goals. They belong together.
We can explain what researchers are investigating, attribute their findings clearly and be open about the stage the work has reached. We can also say that the subject is fascinating.
The fact that we cannot leap ahead of the evidence does not mean we have to pretend the evidence being gathered is uninteresting.
For me, responsible curiosity means neither exaggerating what has been found nor brushing it aside.
A mushroom, a molecule and a finished product
One distinction helps keep this story clear. This project is investigating particular compounds and their potential development into therapeutics. It is not a clinical trial of every Lion’s Mane capsule, powder or liquid extract on the shelf, and its findings cannot simply be transferred to a finished supplement.
That doesn’t take away from the story. It tells us what the story actually is.
Lion’s Mane contains compounds that have prompted researchers to ask serious questions about the brain. Those questions are now receiving further funding and investigation.
That is compelling enough without adding promises the research has not made.
Why I’ll be watching
What interests me most is the space between what we already know and what we have yet to understand.
Lion’s Mane sits in that space. It has attracted plenty of attention in the wellness world, but there is also a more precise scientific conversation happening around its chemistry and biological activity.
This UQ project is part of that conversation.
My position isn’t that a research grant settles the matter. It’s that it gives us another reason not to dismiss the subject.
We don’t need to call Lion’s Mane a miracle to recognise that something interesting is being investigated. And we don’t need all the answers before deciding the questions are worth asking.
I’ll be watching where this research leads.
Shane, Founder, Valley Botanicals
Continue Reading
University of Queensland: Mushroom molecules spark new Alzheimer’s research
Australian Government grant record: Nootropics and neurogenesis